Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

PURPOSE: To provide minimally important difference (MID) estimates for the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 (UCLA SCTC GIT 2.0) in a longitudinal observational cohort. METHODS: We administered the UCLA SCTC GIT 2.0 to 115 patients with SSc at 2 time points 6 mont...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Khanna, Dinesh, Furst, Daniel E., Maranian, Paul, Seibold, James R., Impens, Ann, Mayes, Maureen D., Clements, Philip J., Getzug, Terri, Hays, Ron D.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368014/
https://ncbi.nlm.nih.gov/pubmed/21724699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.110225
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires